Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2004
DOI: 10.1016/j.jmgm.2003.08.001
|View full text |Cite
|
Sign up to set email alerts
|

Molecular modeling of σ1 receptor ligands: a model of binding conformational and electrostatic considerations

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
28
0

Year Published

2004
2004
2024
2024

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 36 publications
(29 citation statements)
references
References 50 publications
(63 reference statements)
1
28
0
Order By: Relevance
“…The overall pharmacophores are the triangles including nitrogen, the center of the phenyl ring, and the lone pair of electrons. These are in agreement with our previous 1 receptor ligands pharmacophore 33 ( Fig. 5b) and in close agreement with our first published pharmacophore 34 (Fig.…”
Section: Pharmacophore Informationsupporting
confidence: 94%
“…The overall pharmacophores are the triangles including nitrogen, the center of the phenyl ring, and the lone pair of electrons. These are in agreement with our previous 1 receptor ligands pharmacophore 33 ( Fig. 5b) and in close agreement with our first published pharmacophore 34 (Fig.…”
Section: Pharmacophore Informationsupporting
confidence: 94%
“…42 Based on this hypothesis Manallack et al and Gund et al superimposed independently different r ligands and defined a distance between the phenyl ring and the basic amino moiety of 5.06 Å (Manallack) and 5.3-5.7 Å (Gund), respectively. [43][44][45] In 1992 Gilligan et al published a r pharmacophore model, which defines the orientation and distances of two 'hydrophobic groups' and one 'basic nitrogen center' to each other for potent r 1 ligands. 46 (Fig.…”
Section: Pharmacophore Models Of R 1 Ligandsmentioning
confidence: 99%
“…Gund et al (2004) employed the PD144418 structure in molecular modeling work to help establish a s 1 receptor pharmacophore. Navarro and coworkers (2010) used the ligand in vitro during their characterization of functional heteromers of s 1 and dopamine D 1 receptors.…”
Section: Introductionmentioning
confidence: 99%